Bassan, R., Pogliani, E., Lerede, T., Fabris, P., Rossi, G., Morandi, S., Casula, P., Lambertenghi-Deliliers, G., Vespignani, M., Izzi, T., Coser, P., Corneo, G. and Barbui, T. (1999) “Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study”, Haematologica. Pavia, Italy, 84(12), pp. 1088-1093. Available at: https://haematologica.org/article/view/1540 (Accessed: 17November2026).